Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S.Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections ReportedThe US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu VaccineThe U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life SciencesModerna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Must-Reads
1
Pumpkins Aren’t Just for Pie—Here’s Why They’re a Superfood
LIFESTYLE
2
What If Hyundai Joined the Pickup Game? Sneak Peek at a Tasman-Based Hyundai Pickup
DEBATE
3
Waymo's Self-Driving Taxis Are Flawed: They Suddenly Spin Around in the Same Spot and Crash
DEBATE
4
Beat the Chill: Simple Ways to Protect Your Joints This Winter
LIFESTYLE
5
Goodbye to the A-10: The Air Force Retires the Warthog After Decades of Service
Moderna’s Stock Soars After CDC Reports First Bird Flu Death in the U.S. Moderna's stock surged over 10% following the first U.S. avian influenza A (H5N1) death, as the company develops a vaccine.
Deadly Bird Flu Detected in US: 3 Human Infections Reported The US Department of Health and Human Services (HHS) announced a $176 million aid to Moderna to develop the bird flu vaccine.
U.S. Government Invests $176M in Moderna for Avian Flu Vaccine The U.S. government announced the plan to provide $176 million to Moderna to develop a pandemic vaccine targeting avian flu.
Moderna Secures $750 Million in Funding to Develop a Flu Vaccine, Backed by Blackstone Life Sciences Moderna is developing a flu vaccine with an investment from Blackstone Life Sciences, a Blackstone life science investment platform. On the 27th (local time), Moderna announced that it had signed a $750 million financing agreement with Blackstone Life Sciences to develop an mRNA flu vaccine. Moderna stated that Blackstone Life Sciences will receive commercial milestone […]
Hot Topics